Shahrokh Javaheri1, Rakesh Shukla2, Laura Wexler3. 1. Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH; Department of Veterans Affairs Medical Center, Cincinnati, OH. Electronic address: javaheri@snorenomore.com. 2. Departments of Medicine and Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH. 3. Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH; Department of Veterans Affairs Medical Center, Cincinnati, OH.
Abstract
BACKGROUND: Excess sudden death due to ventricular tachyarrhythmias remains a major mode of mortality in patients with systolic heart failure. The aim of this study was to determine the association of nocturnal ventricular arrhythmias in patients with low ejection fraction heart failure. We incorporated a large number of known pathophysiologic triggers to identify potential targets for therapy to reduce the persistently high incidence of sudden death in this population despite contemporary treatment. METHODS: Eighty-six ambulatory male patients with stable low (≤ 45%) ejection fraction heart failure underwent full-night attendant polysomnography and simultaneous Holter recordings. Patients were divided into groups according to the presence or absence of couplets (paired premature ventricular excitations) and ventricular tachycardia (VT) (at least three consecutive premature ventricular excitations) during sleep. RESULTS: In multiple regression analysis, four variables (current smoking status, increased number of arousals, plasma alkalinity, and old age) were associated with VT and two variables (apnea-hypopnea index and low right ventricular ejection fraction) were associated with couplets during sleep. CONCLUSIONS: We speculate that cessation of smoking, effective treatment of sleep apnea, and plasma alkalosis could collectively decrease the incidence of nocturnal ventricular tachyarrhythmias and the consequent risk of sudden death, which remains high despite the use of β blockades.
BACKGROUND:Excess sudden death due to ventricular tachyarrhythmias remains a major mode of mortality in patients with systolic heart failure. The aim of this study was to determine the association of nocturnal ventricular arrhythmias in patients with low ejection fraction heart failure. We incorporated a large number of known pathophysiologic triggers to identify potential targets for therapy to reduce the persistently high incidence of sudden death in this population despite contemporary treatment. METHODS: Eighty-six ambulatory male patients with stable low (≤ 45%) ejection fraction heart failure underwent full-night attendant polysomnography and simultaneous Holter recordings. Patients were divided into groups according to the presence or absence of couplets (paired premature ventricular excitations) and ventricular tachycardia (VT) (at least three consecutive premature ventricular excitations) during sleep. RESULTS: In multiple regression analysis, four variables (current smoking status, increased number of arousals, plasma alkalinity, and old age) were associated with VT and two variables (apnea-hypopnea index and low right ventricular ejection fraction) were associated with couplets during sleep. CONCLUSIONS: We speculate that cessation of smoking, effective treatment of sleep apnea, and plasma alkalosis could collectively decrease the incidence of nocturnal ventricular tachyarrhythmias and the consequent risk of sudden death, which remains high despite the use of β blockades.
Authors: Faiez Zannad; John J V McMurray; Henry Krum; Dirk J van Veldhuisen; Karl Swedberg; Harry Shi; John Vincent; Stuart J Pocock; Bertram Pitt Journal: N Engl J Med Date: 2010-11-14 Impact factor: 91.245
Authors: Kengo Usui; T Douglas Bradley; Jonas Spaak; Clodagh M Ryan; Toshihiko Kubo; Yasuyuki Kaneko; John S Floras Journal: J Am Coll Cardiol Date: 2005-06-21 Impact factor: 24.094
Authors: P A Lanfranchi; A Braghiroli; E Bosimini; G Mazzuero; R Colombo; C F Donner; P Giannuzzi Journal: Circulation Date: 1999-03-23 Impact factor: 29.690
Authors: C M Ryan; J S Floras; A G Logan; R J Kimoff; F Series; D Morrison; K A Ferguson; I Belenkie; M Pfeifer; J Fleetham; P J Hanly; M Smilovitch; M Arzt; T D Bradley Journal: Eur Respir J Date: 2010-03 Impact factor: 16.671
Authors: S Javaheri; T J Parker; J D Liming; W S Corbett; H Nishiyama; L Wexler; G A Roselle Journal: Circulation Date: 1998-06-02 Impact factor: 29.690
Authors: Ken Monahan; Amy Storfer-Isser; Reena Mehra; Eyal Shahar; Murray Mittleman; Jeff Rottman; Naresh Punjabi; Mark Sanders; Stuart F Quan; Helaine Resnick; Susan Redline Journal: J Am Coll Cardiol Date: 2009-11-03 Impact factor: 24.094
Authors: Ambarish Pandey; Minesh Patel; Ang Gao; Benjamin L Willis; Sandeep R Das; David Leonard; Mark H Drazner; James A de Lemos; Laura DeFina; Jarett D Berry Journal: Am Heart J Date: 2014-11-12 Impact factor: 4.749
Authors: Emily Banks; Grace Joshy; Rosemary J Korda; Bill Stavreski; Kay Soga; Sam Egger; Cathy Day; Naomi E Clarke; Sarah Lewington; Alan D Lopez Journal: BMC Med Date: 2019-07-03 Impact factor: 8.775